The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies.

To enhance our understanding of the autosomal recessive limb-girdle muscular dystrophy (LGMD), patients from six genetically distinct forms (LGMD2A to LGMD2F) were studied with antibodies directed against four sarcoglycan subunits (alpha-, beta-, gamma-, delta-SG), dystrophin, beta-dystroglycan (beta-DG) and merosin. All patients with LGMD2A and 2B had a mild clinical course while those with a primary sarcoglycan mutation (LGMD2C to 2F) had a range of clinical severity. Dystrophin and merosin immunofluorescence pattern was positive in patients with all six AR LGMDs. The majority of patients with a severe Duchenne-like phenotype presented total absence of the SG complex. However, some exceptions were found in 13q linked patients, indicating that the presence of a certain labelling for components of the SG may not be prognostic for a milder phenotype. The observation that the primary absence of alpha-SG results in the total absence of beta- and delta-SG but not of gamma-SG suggests that the alpha-, beta- and delta-subunits of sarcoglycan may be more closely associated. A secondary reduction in dystrophin amount was seen in patients with primary sarcoglycan mutations, which was most marked in patients with primary beta-, gamma- and delta-SG deficiencies. In contrast, beta-DG staining was retained in all patients, suggesting that the association between SG and DG subcomplexes is not so strong. Based on the above findings, we have refined the model for the interaction among the known glycoproteins of the sarcoglycan complex, within the DGC.

[1]  K. Bushby,et al.  Abnormalities in α-, β- and γ-sarcoglycan in patients with limb-girdle muscular dystrophy , 1996, Neuromuscular Disorders.

[2]  L. Kunkel,et al.  Genomic screening for beta-sarcoglycan gene mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E). , 1996, Human molecular genetics.

[3]  M. Passos-Bueno,et al.  Autosomal recessive limbgirdle muscular dystrophy, LGMD2F, is caused by a mutation in the δ–sarcoglycan gene , 1996, Nature Genetics.

[4]  G. Viglietto,et al.  Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein. , 1996, Human molecular genetics.

[5]  M. Passos-Bueno,et al.  Linkage analysis in autosomal recessive limb-girdle muscular dystrophy (AR LGMD) maps a sixth form to 5q33-34 (LGMD2F) and indicates that there is at least one more subtype of AR LGMD. , 1996, Human molecular genetics.

[6]  J. Weissenbach,et al.  Genetic and physical mapping at the limb-girdle muscular dystrophy locus (LGMD2B) on chromosome 2p. , 1996, Genomics.

[7]  K. Bushby,et al.  Main clinical features of the three mapped autosomal recessive limb-girdle muscular dystrophies and estimated proportion of each form in 13 Brazilian families. , 1996, Journal of medical genetics.

[8]  L. Kunkel,et al.  Mutations in the Dystrophin-Associated Protein γ-Sarcoglycan in Chromosome 13 Muscular Dystrophy , 1995, Science.

[9]  L. Kunkel,et al.  β–sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex , 1995, Nature Genetics.

[10]  K. Campbell,et al.  A common missense mutation in the adhalin gene in three unrelated Brazilian families with a relatively mild form of autosomal recessive limb-girdle muscular dystrophy. , 1995, Human molecular genetics.

[11]  J. Beckmann,et al.  Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity , 1995, Nature Genetics.

[12]  Isabelle Richard,et al.  Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A , 1995, Cell.

[13]  K. Bushby.  Diagnostic criteria for the limb-girdle muscular dystrophies: Report of the ENMC consortium on limbgirdle dystrophies , 1995, Neuromuscular Disorders.

[14]  L. Kunkel,et al.  Human adhalin is alternatively spliced and the gene is located on chromosome 17q21. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Beckmann,et al.  Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy , 1994, Cell.

[16]  H. Yamamoto,et al.  Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl beta-D-glucoside. , 1994, European journal of biochemistry.

[17]  K. Bushby,et al.  A gene for autosomal recessive limb-girdle muscular dystrophy maps to chromosome 2p. , 1994, Human molecular genetics.

[18]  J. Beckmann,et al.  Severe childhood autosomal recessive muscular dystrophy with the deficiency of the 50 kDa dystrophin-associated glycoprotein maps to chromosome 13q12. , 1993, Human molecular genetics.

[19]  J. Weissenbach,et al.  Evidence of genetic heterogeneity in the autosomal recessive adult forms of limb-girdle muscular dystrophy following linkage analysis with 15q probes in Brazilian families. , 1993, Journal of medical genetics.

[20]  M. Pericak-Vance,et al.  Linkage of Tunisian autosomal recessive Duchenne–like muscular dystrophy to the pericentromeric region of chromosome 13q , 1992, Nature Genetics.

[21]  K. Campbell,et al.  Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy , 1992, Nature.

[22]  Hideko Yamamoto,et al.  Glycoprotein‐binding site of dystrophin is confined to the cysteine‐rich domain and the first half of the carboxy‐terminal domain , 1992, FEBS letters.

[23]  M. Johnson,et al.  Dystrophin or a “related protein” in Duchenne muscular dystrophy? , 1992, Acta neurologica Scandinavica.

[24]  M. Vincent,et al.  Dystrophin: a sensitive and reliable immunochemical assay in tissue and cell culture homogenates. , 1991 .

[25]  J. Ervasti,et al.  Membrane organization of the dystrophin-glycoprotein complex , 1991, Cell.

[26]  M. Passos-Bueno,et al.  Immunofluorescence dystrophin study in Duchenne dystrophy through the concomitant use of two antibodies directed against the carboxy-terminal and the amino-terminal region of the protein , 1991, Journal of the Neurological Sciences.

[27]  J. Beckmann,et al.  A gene for limb-girdle muscular dystrophy maps to chromosome 15 by linkage. , 1991, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[28]  E. Ozawa,et al.  Glycoprotein complex anchoring dystrophin to sarcolemma. , 1990, Journal of biochemistry.

[29]  J. Ervasti,et al.  Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle , 1990, Nature.

[30]  R. Waterston,et al.  Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. , 1988, The New England journal of medicine.

[31]  Eric P. Hoffman,et al.  Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.

[32]  V. Dubowitz,et al.  Quantitation of muscle function in children: A prospective study in duchenne muscular dystrophy , 1982, Muscle & nerve.

[33]  J. Walton.  DISORDERS OF VOLUNTARY MUSCLE , 1964, The Ulster Medical Journal.

[34]  P. Vignos,et al.  Maintenance of ambulation in childhood muscular dystrophy. , 1960, Journal of chronic diseases.